ASSURE Wearable ECG vs Zio XT ECG Monitoring System

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Kestra Medical Technologies
VS
by iRhythm Technologies, Inc.

AI Verdict

Both tools offer FDA-cleared wearable ECG monitoring for cardiac patients, utilizing AI for analysis and providing data to clinicians. The key difference lies in Kestra's ASSURE Wearable ECG being a non-therapeutic device for continuous heart rate monitoring, often used after a patient has completed use of their ASSURE Wearable Cardioverter Defibrillator (WCD), while iRhythm's Zio XT is a single-lead biosensor for up to 14 days of continuous cardiac monitoring with a focus on arrhythmia detection. While both are direct competitors in the wearable ECG monitoring space, Kestra's offering appears to be an extension of a broader cardiac recovery system, whereas Zio XT is a standalone diagnostic monitoring service.

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if your patients require continuous, multi-channel heart rate monitoring with advanced artifact filtering, particularly for at-risk cardiac patients needing ongoing oversight. Its integrated digital healthcare platform and Kestra CareStation provide comprehensive clinician review of physiologic trend data and alert-based notifications for proactive management.

View ASSURE Wearable ECG →

Choose Zio XT ECG Monitoring System if…

Choose Zio XT ECG Monitoring System if you need a convenient, short-term diagnostic solution for suspected arrhythmias, offering up to 14 days of continuous monitoring. Its water-resistant, wire-free design promotes high patient compliance and comfort, while FDA-cleared AI and expert review provide accurate arrhythmia detection for diagnostic purposes.

View Zio XT ECG Monitoring System →

For physicians evaluating cardiac monitoring solutions, the ASSURE Wearable ECG and Zio XT ECG Monitoring System offer distinct advantages. The ASSURE Wearable ECG, from Kestra Medical Technologies, excels in continuous, multi-channel heart rate monitoring and data collection, integrated into a comprehensive digital healthcare platform. Its key features include a SensorFit Garment with cushioned ECG sensors, the Quad Channel Processing™ ASSURE Detection Algorithm, and Adaptive Patient Intelligence™ for motion artifact filtering. This system is best suited for at-risk cardiac patients requiring detailed, ongoing physiologic trend data and alert-based notifications, with clinician review facilitated through the Kestra CareStation remote patient data platform.

In contrast, the Zio XT ECG Monitoring System by iRhythm Technologies provides a wearable, single-lead ECG biosensor for up to 14 days of continuous ambulatory monitoring. Its strength lies in its simplicity, high patient compliance, and FDA-cleared deep-learned AI algorithm for accurate arrhythmia detection and diagnosis, complemented by expert review. The practical difference is that ASSURE offers a multi-channel approach with advanced artifact filtering for potentially more granular data, while Zio XT prioritizes ease of use, extended wear time, and a streamlined diagnostic pathway with its proprietary AI and expert analysis. Physicians prioritizing comprehensive, multi-channel data and a robust digital platform for complex cardiac patients may lean towards ASSURE. Those seeking a highly compliant, user-friendly, and efficient solution for arrhythmia detection over an extended period, particularly across cardiology, emergency medicine, and internal medicine, would likely find Zio XT more appropriate.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ASSURE Wearable ECG Zio XT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. Cloud-based (AWS EC2 platform), no on-premise hardware required.
FDA Status Cleared AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

The Zio XT is a single-lead, water-resistant patch that can be worn for up to 14 days, including during showers and exercise, and has no external wires, which patients generally prefer over traditional Holter monitors. While some users report skin irritation, the overall patient satisfaction and compliance rates are high. The ASSURE Wearable ECG also offers a comfortable, non-adhesive design, but the Zio XT's extended wear time and water resistance give it an edge in patient convenience and continuous monitoring capabilities.

Clinical Value

Zio XT ECG Monitoring System

The Zio XT has demonstrated a higher diagnostic yield for cardiac arrhythmias compared to Holter monitors, leading to changes in clinical management, such as the initiation of anticoagulants. It also offers a significantly shorter time to results and a reduced need for outpatient appointments. While the ASSURE Wearable ECG has strong clinical study results for its WCD system, including 100% successful conversion for VT/VF events and a low inappropriate-shock rate, the Zio XT's extensive evidence base for diagnostic accuracy in a broader range of arrhythmias gives it a slight advantage for overall clinical value in long-term monitoring.

Pricing & Value

Zio XT ECG Monitoring System

The Zio XT has publicly available pricing information for the UK (£310 per patient) and proposed Medicare rates in the US (approximately $229-$260.35), which includes the biosensor, analysis, and data reporting. iRhythm also offers financial assistance programs and payment options for patients. Kestra Medical Technologies requires direct contact for pricing details, making it less transparent. Additionally, studies suggest Zio XT can be cost-saving in certain clinical pathways.

Enterprise Readiness

Zio XT ECG Monitoring System

iRhythm Technologies, with its Zio XT system, has a significant market presence, having served over 8 million patients and analyzed over 1.5 billion hours of heartbeat data. Their cloud-based platform (ZEUS) and FDA-cleared AI algorithm demonstrate a robust and scalable enterprise solution. Kestra Medical Technologies is also growing rapidly and has established partnerships, but the sheer volume of patients served and data analyzed by iRhythm suggests a more mature and proven enterprise-ready solution.

Innovation

Zio XT ECG Monitoring System

iRhythm Technologies has a strong focus on innovation, particularly in its FDA-cleared deep-learned AI algorithm for ECG data analysis, which has shown improved accuracy over time. They continuously invest in research and development, with a growing body of clinical evidence and new product iterations. Kestra Medical Technologies also emphasizes innovation in its wearable defibrillator system, including algorithm updates and a focus on patient compliance. However, iRhythm's long-standing commitment to AI advancement and extensive data analysis gives it an edge in this dimension.

Support & Docs

Zio XT ECG Monitoring System

iRhythm Technologies provides comprehensive customer support through phone, email, and online chat, with dedicated resources for patients and healthcare professionals, including financial navigators and patient support FAQs. They also offer extensive clinical documentation and case studies. Kestra Medical Technologies offers an ASSURE Helpline for patients and providers and contact information for investor relations, but the breadth and accessibility of iRhythm's support resources appear more extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ASSURE Wearable ECG Zio XT ECG Monitoring System
Device Type Wearable ECG device Wearable single-lead ECG biosensor
Monitoring Duration Continuous heart rate monitoring (duration not specified) Up to 14 days of continuous cardiac monitoring
Sensor Technology SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors Single-lead ECG biosensor, no external leads or wires
Data Analysis ASSURE Detection Algorithm with Quad Channel Processing, Adaptive Patient Intelligence for filtering motion artifacts Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis
Patient Interaction Alert-based notifications Patient-activated button for symptomatic event logging
Data Platform Kestra CareStation remote patient data platform Cloud-based software platform (ZEUS) for data storage, analysis, and reporting
Water Resistance Not specified Water-resistant design for normal daily activities, including showering
Mobile App Yes, the ASSURE Patient App is available Not specified

Videos

Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ASSURE Wearable ECG provides continuous heart rate monitoring and data collection. In contrast, the Zio XT ECG Monitoring System offers continuous ambulatory cardiac monitoring for up to 14 days using a single-lead ECG biosensor.
The ASSURE Wearable ECG utilizes a SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors. The Zio XT ECG Monitoring System features a water-resistant, single-lead biosensor with no external leads or wires, designed for enhanced patient comfort and high compliance during daily activities, including showering.
The ASSURE Wearable ECG employs the ASSURE Detection Algorithm with Quad Channel Processingu2122 and Adaptive Patient Intelligenceu2122 for filtering motion artifacts. The Zio XT ECG Monitoring System uses a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis.
Clinicians review data from the ASSURE Wearable ECG via the Kestra CareStation remote patient data platform, which provides alert-based notifications and physiologic trend data. The Zio XT ECG Monitoring System utilizes the cloud-based ZEUS software platform for data storage, analysis, and reporting.
The Zio XT ECG Monitoring System is a wearable single-lead ECG biosensor. The ASSURE Wearable ECG, while not explicitly stating lead count, mentions a SensorFit Garment with embedded sensors and Quad Channel Processingu2122, suggesting a multi-channel approach.
The ASSURE Wearable ECG is primarily indicated for Cardiology. The Zio XT ECG Monitoring System serves Cardiology, Emergency Medicine, and Internal Medicine specialties.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.